Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of Misoprostol and PGE2 Gel for Induction of Labour in Premature Rupture of Membranes at Term
This study is currently recruiting participants.
Verified by Nilratan Sircar Medical College, June 2008
Sponsored by: Nilratan Sircar Medical College
Information provided by: Nilratan Sircar Medical College
ClinicalTrials.gov Identifier: NCT00355303
  Purpose

The purpose of this study is to determine whether induction of labour with vaginal misoprostol application will result in fewer caesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at Term.


Condition Intervention Phase
Premature Rupture of Membranes at Term
Drug: Misoprostol in arm A & PGE2 Gel in arm B
Phase IV

Drug Information available for: Misoprostol Dinoprostone
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Nilratan Sircar Medical College:

Primary Outcome Measures:
  • Caesarean Section rate [ Time Frame: 48 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Induction delivery time, [ Time Frame: 48 hours ] [ Designated as safety issue: No ]
  • Neonatal & maternal infectious morbidity [ Time Frame: till discharge from hospital or death ] [ Designated as safety issue: No ]

Estimated Enrollment: 1300
Study Start Date: August 2006
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
misoprostol -A & PGE2 gel-B: Active Comparator
participants are assigned to one of two arms for the duration of the study In arm A of study induction of labour is done by intravaginal misoprostol & in arm B, induction of labour is done by PGE2 gel application in posterior fornix and the outcomes will be compared
Drug: Misoprostol in arm A & PGE2 Gel in arm B
In arm A Intravaginal Misoprostol is applied 25 microgram 4 hourly a maximum of five doses. In arm B PGE2 gel is applied at 6 hour interval with a maximum of 2 doses.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Premature rupture of membranes at 37 or more weeks
  • Single live fetus in cephalic presentation

Exclusion Criteria:

  • Women in labour
  • Women with contraindication of induction of labour
  • Women with previous caesarean section or uterine surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00355303

Contacts
Contact: Snehamay Chaudhuri, MBBS,MD,DNB 91-33-23537900 snehamay_chaudhuri_dr@yahoo.com

Locations
India, West Bengal
Nilratan Sircar Medical College, 138,AJC Bose Road, Recruiting
Kolkata, West Bengal, India, 700014
Contact: Snehamay Chaudhuri, MBBS,MD,DNB     91-33-23537900     snehamay_chaudhuri_dr@yahoo.com    
Sponsors and Collaborators
Nilratan Sircar Medical College
Investigators
Principal Investigator: Snehamay Chaudhuri, MBBS,MD.DNB Nilratan Sircar Medical College , Kolkata, West bengal , India
  More Information

Chaudhuri S, Mitra S N, Biswas PK et al,Premature Rupture Of Membranes At Term : Immediate Induction With PGE2 gel Compared with Delayed Induction with Oxytocin , J Obstet and Gynaecol India , Vol 56, No 3: 2006, 224-229  This link exits the ClinicalTrials.gov site

Responsible Party: Nilratan Sircar Medical College , West Bengal , Kolkata ( Dr Snehamay Chaudhuri, Assistant Professor , Department of Gyne & Obstetrics )
Study ID Numbers: 2-Chaudhuri
Study First Received: July 19, 2006
Last Updated: July 2, 2008
ClinicalTrials.gov Identifier: NCT00355303  
Health Authority: India: Ministry of Health

Keywords provided by Nilratan Sircar Medical College:
Premature rupture of membranes at term
Induction of labour
Misoprostol
PGE2 gel
Immediate induction with PGE2 gel
Immediate induction with Misoprostol

Study placed in the following topic categories:
Dinoprostone
Pregnancy Complications
Misoprostol
Wounds and Injuries
Obstetric Labor Complications
Disorders of Environmental Origin
Rupture
Fetal Membranes, Premature Rupture

Additional relevant MeSH terms:
Oxytocics
Therapeutic Uses
Anti-Ulcer Agents
Abortifacient Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Reproductive Control Agents
Abortifacient Agents, Nonsteroidal
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009